Cancer Profiling Market Key Finding, Latest Trends Progression Status, & Revenue Analysis

0
13
Cancer Profiling Market

Comprehensive Analysis Report of Global Cancer Profiling Market

Markntel Advisors has recently published a comprehensive analysis report of the Global Cancer Profiling Market, spanning the forecast period from 2024 to 30. Leveraging data from the historical period of 2019 to 22, with 2023 as the reference year, our expert team of analysts has dedicated significant effort to collect and evaluate the latest market data. The outcome is a detailed and up-to-date report that provides valuable insights for individuals making data-driven decisions, including business owners and analysts. Whether your goal is to explore new markets, launch a new product, or maintain a competitive advantage, our research report on the Cancer Profiling Market presents well-researched facts and figures pertinent to the industry.

Link to Download Report Free Sample – https://www.marknteladvisors.com/query/request-sample/cancer-profiling-market.html

Study Report Coverage:

  1. Industry Overview and Statistics
  2. Trends in the Global Cancer Profiling Market
  3. Factors Driving and Hindering Industry Growth
  4. Evolution of the Industry by Geography and Service Adoption
  5. Competition Across Various Regions
  6. Evolution of Customer Buying Behavior and Expectations
  7. Key Competitors and Strategic Partnerships

Unlocking Insights: The Global Cancer Profiling Market (2024-2030)

The Global Cancer Profiling Market size is estimated to grow at a CAGR of around 11.5% during the forecast period, i.e., 2024-30.

Leading Companies Operating in the Cancer Profiling Market:

  • NeoGenomics Laboratories
  • Eurofins Genomics GmbH
  • Hoffmann-La Roche Ltd (Foundation Medicine)
  • OncoDNA SA
  • 10x Genomics, Inc.
  • Caris Life Sciences.
  • Geneseeq Technology Inc.
  • Genetron Holdings Limited
  • Laboratory Corporation of America Holdings (LabCorp)
  • Dante Labs Inc.
  • Celemics, Inc.
  • Strand Life Sciences
  • Myriad Genetics, Inc.
  • QIAGEN GmbH
  • Tempus Labs
  • Other

Have Any Query? Ask Our Analyst @: https://www.marknteladvisors.com/query/talk-to-our-consultant/cancer-profiling-market.html

Geographical Reach and Leading Area

  • North America
  • South America
  • Europe
  • Middle East & Africa
  • Asia Pacific

Among all, North America holds the dominant position in the Global Cancer Profiling Market.

Segments and Sub-Section of Cancer Profiling Market:

By Type of Cancer

  • Breast Cancer – Market Size & Forecast 2019-2030, USD Million
  • Colorectal Cancer – Market Size & Forecast 2019-2030, USD Million
  • Gynecological Cancer – Market Size & Forecast 2019-2030, USD Million
  • ‎Leukemia – Market Size & Forecast 2019-2030, USD Million
  • Prostate Cancer – Market Size & Forecast 2019-2030, USD Million
  • Lung Cancer – Market Size & Forecast 2019-2030, USD Million
  • Others (Pancreatic Cancer, Skin Cancer, etc.) – Market Size & Forecast 2019-2030, USD Million

By Technology

  • Next-Generation Sequencing – Market Size & Forecast 2019-2030, USD Million
  • Polymerase Chain Reaction – Market Size & Forecast 2019-2030, USD Million
  • Mass Spectrometry – Market Size & Forecast 2019-2030, USD Million
  • In-Situ Hybridization – Market Size & Forecast 2019-2030, USD Million
  • Microarrays Analysis – Market Size & Forecast 2019-2030, USD Million
  • Others (Single-Cell Sequencing, etc.) – Market Size & Forecast 2019-2030, USD Million

By Biomarker Type

  • Genomic Biomarkers- Market Size & Forecast 2019-2030, USD Million
  • Proteomics Biomarkers- Market Size & Forecast 2019-2030, USD Million
  • Others (Epigenetic Biomarkers, Metabolomics Biomarkers, etc.)- Market Size & Forecast 2019-2030, USD Million

By Cell Type

  • Germline – Market Size & Forecast 2019-2030, USD Million
  • Somatic – Market Size & Forecast 2019-2030, USD Million

By Application

  • Oncology Research – Market Size & Forecast 2019-2030, USD Million
  • Precision Medicine – Market Size & Forecast 2019-2030, USD Million
  • Clinical Diagnostics – Market Size & Forecast 2019-2030, USD Million
  • Others (Prognosis, Monitoring and Recurrence Detection, etc.) – Market Size & Forecast 2019-2030, USD Million

By End-User

  • Hospitals and Clinics – Market Size & Forecast 2019-2030, USD Million
  • Research Institutions and Laboratories – Market Size & Forecast 2019-2030, USD Million
  • Diagnostic Service Providers – Market Size & Forecast 2019-2030, USD Million
  • Pharmaceutical and Biotechnology Companies – Market Size & Forecast 2019-2030, USD Million

Need more detailed analysis? We’re here to help! Click to the Link to unlock additional specific information tailored to your requirements – https://www.marknteladvisors.com/query/request-customization/cancer-profiling-market.html

About us

MarkNtel Advisors is a leading consulting, data analytics, and market research firm that provides an extensive range of strategic reports on diverse industry verticals. We being a qualitative & quantitative research company, strive to deliver data to a substantial & varied client base, including multinational corporations, financial institutions, governments, and individuals, among others.

We have our existence across the market for many years and have conducted multi-industry research across 80+ countries, spreading our reach across numerous regions like America, Asia-Pacific, Europe, the Middle East & Africa, etc., and many countries across the regional scale, namely, the US, Saudi Arabia, the Netherlands, Saudi Arabia, the UAE, Brazil, and several others.

Contact Information: